- This is a narrative review of perioperative care for patients with resectable non-small cell lung cancer treated with immune checkpoint inhibitors, with no pooled sample or quantitative analysis.
- It compares immunochemotherapy with chemotherapy alone, and notes that myocarditis and pneumonitis are the most fatal perioperative immune-related adverse events, sometimes requiring surgical delay of up to 6 weeks.
- Most recent trials report no increased surgical complexity after immunochemotherapy, though the authors caution that cycle number, surgical timing, and surgeon-difficulty grading are not standardized.
- The authors urge anesthesiologists to screen for immune-related adverse events and surgical complexity predictors within a multidisciplinary team, and flag opioid effects and prehabilitation as areas needing research.
Cardiac
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- This comprehensive review covers perioperative anesthetic management of patients with durable or temporary left ventricular assist devices undergoing non-cardiac surgery.
- It addresses preoperative device interrogation, right ventricular assessment, volume optimization, and anticoagulation planning, plus intraoperative monitoring of arterial pressure, TEE when feasible, preload, afterload, and pump flow.
- Key goals highlighted are maintaining mean arterial pressure, preventing right-heart failure, avoiding suction events, and routinely checking device function.
- The authors conclude that non-cardiac surgery can be performed safely at specialized centers with standardized protocols, advanced monitoring, and structured team education, with postoperative care in an intensive care setting familiar with mechanical circulatory support.
- Descriptive software development and validation study using 50 simulated scenarios derived from real cardiac surgical cases, reviewed by three senior cardiac anesthesiologists.
- The authors built a web-based app (CCA Pro v6.0) combining six modules: coagulation, blood gas, ventilation, hemodynamics, ECMO, and AI extraction of values from device photos.
- The app reportedly agreed with expert consensus across coagulation, acid-base, ventilator, and ECMO scenarios, but the abstract reports no quantitative agreement statistics.
- The authors suggest it could reduce cognitive load and dosing errors, and state that prospective clinical validation is warranted.
- A prospective single-center study of 30 neonates and infants undergoing cardiopulmonary bypass cardiac surgery at a US tertiary hospital.
- No intervention was given; patients with an adequate heparin response were compared with those with an inadequate response on coagulation factor levels.
- Antithrombin levels were similar between groups, while α2-macroglobulin and protein S were significantly lower in the inadequate-response group.
- The authors suggest that lower α2-macroglobulin and protein S may partly explain inadequate heparin response in this cohort.
- Retrospective cohort of 973 patients with LVEF ≤30% undergoing CABG with or without valve surgery, using an institutional cardiac surgery database.
- Compared preoperative levosimendan administration against no levosimendan, with causal analysis using machine learning double-robust methods.
- Estimated average treatment effect on 30-day mortality was 0.12 percentage points (95% CI, -0.84 to 1.56), and the double-robust TMLE estimate was 1.08 percentage points (95% CI, -6.66 to 10.71).
- Authors conclude levosimendan does not significantly change 30-day mortality in this population; age, renal function, and surgical complexity were the dominant predictors.
- This narrative review summarizes anatomy, mechanism, and physiology of stellate ganglion block (SGB) in refractory ventricular tachycardia and electrical storm, and reviews the supporting literature.
- The review covers SGB as an add-on to standard antiarrhythmic, ablation, and circulatory support strategies for refractory ventricular arrhythmias.
- Observational studies, case series, retrospective studies, and meta-analyses report that SGB can reduce arrhythmia episodes, but the abstract gives no effect sizes.
- The authors judge the evidence weak because no randomized controlled trials exist, and they suggest SGB may serve as bridge therapy until long-term management.
- Retrospective single-center cohort of 432 patients aged 65 or older who had elective open cardiac surgery between 2018 and 2023.
- Preoperative systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio were compared between patients with poor and good early postoperative prognosis.
- Poor prognosis occurred in 98 patients (22.7%); those patients had higher preoperative NLR and PLR, higher EuroSCOREs, longer ICU and hospital stays, and more short-term mortality (all p < 0.05).
- The authors judged PLR and NLR simple but moderately predictive, with SII showing limited value, and reported that postoperative indices at 72 hours were more strongly associated with adverse outcomes.
- A UK survey of cardiothoracic anesthesiologists, sent via ACTACC email and departmental contacts, had 153 responses from 461 invited (33%).
- The survey asked about TEE accreditation status, pathways, and motivations and barriers for obtaining or maintaining it; no intervention was given.
- Fifty-three percent of respondents held valid TEE certification, and 80% considered maintaining accreditation valuable; the European pathway was the most popular (44%).
- The authors conclude current systems do not appear to meet UK cardiac anesthesia workforce needs and call for national guidelines and a tailored perioperative TEE curriculum.
- Prospective randomized paired-kidney study at one tertiary center, with 40 recipients from 20 brain-dead donor pairs.
- Recipients were randomized to FloTrac-guided goal-directed therapy targeting stroke volume, or to standard CVP-guided therapy.
- GDHT received less intraoperative IV fluid (1,385.0 ± 259.6 vs 1,958.0 ± 877.0 mL, p = 0.011), and rescue vasopressor use was 45% vs 100% (p = 0.001).
- The authors conclude GDHT safely limits fluid and vasopressor needs, while creatinine trajectories and delayed graft function (10%) were identical between groups.
- This retrospective single-center cohort included 1,368 adults undergoing cardiac surgery between October 2020 and September 2022.
- Exposure was minutes spent in seven MAP bands during the first 24 postoperative hours, compared with the 65-69 mmHg reference band, with AKI assessed from 24 hours to 7 days.
- AKI occurred in 190 patients (15.3%) after prespecified exclusions, and time in no MAP band was associated with AKI (e.g., OR 0.98 per 15 minutes at 60-64 mmHg, 95% CI 0.88-1.08).
- The authors could not demonstrate an association between time in any MAP range and postoperative AKI in this cohort.
- This narrative review covers perioperative care of end-stage renal disease patients on renal replacement therapy undergoing major cardiac surgery.
- It describes preoperative steps such as dialysis timing, electrolyte correction, hemoglobin optimization, and bleeding-risk assessment, plus intraoperative goal-directed fluids and hemofiltration on the bypass circuit.
- The abstract reports no pooled data or quantitative outcomes; it recommends early postoperative renal replacement therapy, with continuous modalities favored in unstable patients.
- The authors stress a multidisciplinary, individualized approach involving cardiologists, nephrologists, anesthesiologists, and cardiac surgeons to reduce complications.
- Randomized, blinded, two-center French superiority trial of 320 adults undergoing elective cardiac surgery with cardiopulmonary bypass.
- Patients received opioid-free anesthesia with ketamine, dexamethasone, lidocaine and magnesium, or opioid anesthesia with sufentanil.
- The 30-day composite of complications or death occurred in 75.4% versus 84.5% (RR 0.90; 95% CI 0.80 to 0.99; P = 0.049), with a fragility index of 1.
- The authors call the results hypothesis generating; cardiovascular and digestive complications and deaths were also lower with opioid-free anesthesia.
- Single-center retrospective observational study of 16,906 consecutive patients who had preoperative spirometry before cardiac surgery between 2010 and 2020.
- Patients were classified by whether they had a documented lung disease diagnosis and whether spirometry showed obstruction, giving four groups.
- In-hospital mortality was 4.5% with diagnosis and obstruction, 3.8% with diagnosis but no obstruction, 2.6% with obstruction but no diagnosis, and 1.8% with neither.
- Of the 27.9% with obstruction on spirometry, 21.7% of those without a diagnosis showed it, and the authors suggest spirometry could aid case finding and treatment optimization.
- Randomized swine study with induced ventricular fibrillation compared TEE-guided compressions over the mid-left ventricle (n = 8) with LVOT-centered compressions (n = 5).
- Mid-left ventricle compressions were compared with LVOT-centered compressions after 10 minutes of basic life support during resuscitation.
- Mid-left ventricle compressions produced higher coronary perfusion pressure (difference 15.6 mmHg; 95% CI 9.8 to 21.5), and LVOT collapse was 82% versus 10%.
- The authors conclude that left ventricle-targeted compressions preserved outflow tract patency and improved hemodynamics, with LVOT collapse correlating with lower perfusion pressures.
- This narrative review searched PubMed, Embase, and the Cochrane Library through September 2025 and organized regional anesthesia options for TAVI by access route.
- For transfemoral TAVI, the review treats local infiltration with monitored anesthesia care as the default, noting that regional anesthesia has not been shown to improve major clinical outcomes.
- Selective adjuncts such as ilioinguinal-iliohypogastric and fascia iliaca blocks may reduce sedative or opioid needs, while for non-transfemoral access regional techniques may preserve ventilation and stabilize hemodynamics.
- The authors conclude that regional anesthesia should be used selectively and that direct comparisons with local infiltration plus monitored anesthesia care are still needed.
- Retrospective multi-institutional study of 33 patients who underwent carotid body tumor excision over 21 years at three tertiary academic hospitals.
- No intervention was studied; preoperative variables were examined as predictors of perioperative outcomes.
- Essential hypertension was correlated with intraoperative hypotension requiring therapy, whereas hypertension measured on the day of surgery was not.
- Blood loss correlated with BMI, tumor greatest dimension and tumor volume; surgical duration and length of stay tracked with tumor size and volume, and the authors frame results as planning aids.
- Prospective cohort of 255 Caucasian adults undergoing elective cardiac surgery via median sternotomy, with pain tracked to 12 months.
- Three CTSG SNPs were genotyped, and CTSG plasma concentration and activity were measured in a random subsample of 107 patients.
- Moderate-to-severe movement pain was uncommon (6.4% at 6 months, 3.3% at 12 months), and rs2236742 AA was linked to higher pain at all three time points (P < .05).
- For rs2070697, GA vs AA gave odds ratios such as 4.642 (95% CI 1.535-14.040, P = .007) at 6 months at rest. The authors call for validation in larger multi-ethnic cohorts.
- Retrospective observational study of 94 patients under 10 years who underwent Fontan surgery at a single tertiary center from 2013 to 2023.
- Pre-extubation respiratory indices, including alveolar dead space fraction (AVDSF), were compared with patients who had unfavorable post-extubation responses, defined as prolonged CVP elevation or inhaled nitric oxide initiation or escalation.
- Unfavorable responses occurred in 17 patients (18%); AVDSF and preoperative pulmonary vascular resistance were independently associated, with an AVDSF cutoff of >0.12 (AUC 0.845, sensitivity 76.5%, specificity 92.2%).
- The authors conclude AVDSF was associated with prolonged CVP elevation after extubation and suggest a value near 0.12 as an exploratory reference point for identifying at-risk patients.
- Retrospective single-center review of 886 children aged 0 to 18 undergoing cardiopulmonary bypass cardiac surgery between 2019 and 2023.
- Exposure was preoperative iron deficiency or iron deficiency anemia, defined by ferritin, hemoglobin, and reticulocyte hemoglobin equivalent; no intervention was given.
- Iron deficiency was linked to larger transfusion volumes (31.2 vs 21.9 mL/kg, p < 0.001) and more acute kidney injury (30.2% vs 20.8%, p = 0.002), and these findings held after adjustment.
- The authors conclude iron deficiency is common and associated with worse outcomes, and they call for prospective studies on managing it in congenital heart disease.
- Prospective observational study of 105 adults undergoing elective noncardiac surgery under general anesthesia at a single tertiary hospital.
- Graded PEEP (0, 5, 10, and 15 cmH2O) was applied during controlled ventilation, with echocardiography and arterial pressure recorded at each step and single-beat Ees calculated by the Chen method.
- For each 5 cmH2O PEEP increase, Ees rose by 0.55 mmHg/mL (95% CI 0.49 to 0.61; p < 0.001) while stroke volume fell by 9.1 mL.
- The authors concluded that the Ees increase reflected stroke-volume sensitivity of the single-beat formula, so it should not be read as improved left-ventricular systolic function.
- A prospective randomized trial at a single tertiary university hospital enrolled 57 patients undergoing elective thoracotomy.
- Patients received preoperative ultrasound-guided paravertebral block or erector spinae plane block at T5 with 20 mL of 0.25% bupivacaine, with remifentanil titrated using the NOL index.
- Intraoperative remifentanil use was lower with PVB (431.4 vs 863.6 mcg, p < 0.001), as was 24-hour postoperative morphine (15.2 vs 20.1 mg, p = 0.002).
- Resting NRS scores were lower with PVB at 9 and 12 hours, and cough NRS scores were lower at all time points; the authors conclude ESPB may be insufficient for major thoracic surgery.
- Single-center, double-blind, placebo-controlled randomized trial of 70 adults with delayed recovery after on-pump cardiac surgery in Cairo, Egypt.
- Enteral levothyroxine (25-50 µg/d, titrated by body mass index) versus identical placebo, started on postoperative day 2 and continued until ICU discharge.
- The levothyroxine group had greater GCS improvement (aMD +7.81; 95% CI 5.24-10.38; p<0.001) and lower 30-day mortality (14.3% vs 45.7%; aHR 0.24; 95% CI 0.09-0.65; p=0.005).
- The authors call the mortality finding hypothesis-generating given only 21 events, and hospital stay was longer with levothyroxine (13.1 vs 10.3 days, p=0.005).
- A retrospective, single-centre observational study of 934 off-pump CABG patients at a university hospital used propensity score matching to create 360 pairs.
- The exposure was afternoon versus morning timing of anesthesia induction.
- Post-induction hypotension occurred in 55.28% of afternoon versus 35.28% of morning inductions (p < 0.001), with adjusted OR 2.38 (95% CI 1.65-3.43).
- The authors call afternoon induction an independent risk factor and report a 5-variable nomogram with C-index about 0.74 in both training and testing sets.
- Retrospective, propensity score-matched cohort at a single academic center, drawn from 400 adults having elective open cardiac surgery with bypass, leaving 51 UFTA and 99 conventional patients.
- The UFTA group used a goal-directed plan aiming for operating room extubation with short-acting, low-dose opioids, compared with ICU extubation after higher-dose opioids.
- Complications were similar (54.9% vs 56.6%, p = 0.846; OR 0.935, 95% CI 0.475 to 1.853), while extubation time was shorter by 747.2 minutes (95% CI -915.0 to -579.4).
- The authors concluded UFTA was not associated with more complications and may aid early recovery, with lower day-0 vasoactive-inotropic scores and fluid intake.
- Single-center randomized controlled study of 122 adults aged 60 or older with preoperative Anticholinergic Cognitive Burden scores of 3 or higher undergoing CABG.
- Patients given a deprescribing strategy that avoided perioperative anticholinergic anesthetic and analgesic drugs were compared with standard care that included them.
- At day 90, full Katz Index independence was more frequent with deprescribing (75.0% vs 41.1%, p < 0.001), and frailty scores were lower (median 3 vs 4, p < 0.001).
- Perioperative anticholinergic use was an independent predictor of 90-day total complications (OR 2.430, 95% CI 1.031-5.726, p = 0.042), and the authors call anticholinergic burden a modifiable risk factor.
- This is a critical narrative review of clinical controversies, not a primary study, and it reports no pooled sample size or quantitative results.
- It explains mechanical power as a single energy-per-unit-time measure that combines tidal volume, pressure, and flow, in contrast to static parameters such as tidal volume and PEEP.
- The authors conclude that current evidence is insufficient to show that mechanical power is independently associated with postoperative pulmonary complications.
- They suggest it may be a reasonable supplement to static parameters in high-risk patients, with excess power curbed by adjusting flow and respiratory rate, and call for standardized studies.
- Single-center retrospective observational study of 15 cesarean deliveries in 13 women with Fontan circulation.
- Compared neuraxial anesthesia (7 cases) with general anesthesia (8 cases), with prophylactic dopamine given to 7 and 5 patients respectively.
- No hypotension occurred under neuraxial anesthesia, whereas 6 patients receiving general anesthesia had transient hypotension treated with vasoactive agents.
- Heart failure needing diuretics developed in 7 patients (3 general, 4 neuraxial); the authors say either approach may be feasible but urge caution given the small sample.
- Randomized, double-blind, placebo-controlled multicenter trial of 80 patients from five French centers who met VA-ECMO weaning criteria.
- Patients received a single 24-hour levosimendan infusion or placebo; the primary endpoint was weaning failure, defined as no weaning within 48 h, another assist device, or death within 7 days.
- Weaning failure occurred in 25% of patients in both groups (OR 1.00, 95% CI 0.36 to 2.75; P = 1.00).
- Acute kidney injury at day 30 was more frequent with levosimendan (62.5% vs 38.5%; OR 2.67, 95% CI 1.08 to 6.62; P = 0.03), which the authors describe as hypothesis generating.
- Retrospective single-center study of 92 patients who underwent Glenn (n = 44) or Fontan (n = 48) procedures between 2019 and 2024.
- Exposure was intraoperative alveolar dead space fraction, measured from paired arterial blood gas and end-tidal CO2 at three points, compared between patients extubated within 24 hours (n = 79) and those ventilated longer (n = 13).
- Dead space fraction was higher in the prolonged-ventilation group at CPB weaning (0.18 vs 0.29, p = 0.01) and at procedure end (0.12 vs 0.26, p = 0.02), with an AUC of 0.70 (95% CI 0.53-0.86) at the end.
- Prolonged-ventilation patients also had longer ventilation, ICU and hospital stays, more cardiovascular reinterventions, and higher in-hospital mortality.
- This narrative expert review surveys machine learning applications across the postcardiotomy shock course, from early risk recognition through tMCS prognostication.
- The review covers ML use in escalation, device configuration, and weaning of temporary mechanical circulatory support, along with model development steps such as feature selection and external validation.
- Evidence is strongest for risk stratification, mortality prediction, and weaning support, mainly in venoarterial ECMO cohorts, but most models are retrospective and lack prospective PCS-specific validation.
- Automated device titration is promising but still preclinical, and the authors position ML as an adjunct to clinician judgment rather than a replacement.
- Prospective single-center cohort of 80 patients undergoing elective abdominal aortic surgery, with serum GLP-1 measured at eight perioperative time points.
- Intestinal ischemia was confirmed by contrast-enhanced MRI or surgery, and six patients developed it; GLP-1 was compared between those with and without ischemia.
- Patients with ischemia had significantly higher GLP-1 at all postoperative time points (P < 0.02), with AUC 0.993 at 24 hours and 0.919 at 6 hours after declamping.
- The authors conclude that elevated GLP-1 shows high specificity for ischemia, independent of diabetes or age, and is a promising predictive biomarker.
- Retrospective three-phase analysis of 380 elective isolated CABG patients from 2024: pre-ERAS (n=238), ERAS without monitoring (n=119), and ERAS with FloTrac monitoring (n=23).
- Compared ERAS with FloTrac-guided hemodynamic monitoring against pre-ERAS care and ERAS without monitoring, with extubation time and ICU length of stay as primary outcomes.
- Mean extubation time fell from 10 hours 17 minutes to 5 hours 54 minutes in the FloTrac phase, a 43% reduction (95% CI -6.26 to -2.50 hours; p < 0.001). Mean hypotension duration fell 74% (p < 0.001).
- The authors attribute the gains to protocol adherence, workflow changes, and real-time feedback rather than FloTrac alone. ICU length of stay did not differ significantly from pre-ERAS (p = 0.472).
- Single-center retrospective cohort of 150 adults undergoing elective cardiac surgery with bypass, excluding those with intraoperative technical surgical complications.
- The study examined bypass duration and immediate post-bypass lactate and leukocyte counts as predictors of a composite unfavorable outcome including mortality, prolonged ventilation, dialysis, neurologic complications, and prolonged norepinephrine.
- A bypass duration of at least 132 minutes was 93% specific for the composite endpoint. In that subgroup (n = 35), a lactate × leukocyte product of at least 72 gave an AUC of 0.909, with 100% sensitivity and 81% specificity.
- The product also correlated with duration of postoperative mechanical ventilation (rho = 0.86, p < 0.0001). The authors suggest it may outperform bypass duration alone.
- A retrospective single-center cohort of 547 infants (median age 6 months) undergoing elective VATS lung resection with one-lung ventilation, 2018-2023.
- The exposure was male sex; all patients received standardized intraoperative management and fast-track extubation, with no intervention assigned.
- Overall PPC incidence was 17.4% (95% CI 14.3-20.8), with boys at 24% versus 11% in girls; the age-adjusted OR was 2.31 (95% CI 1.36-3.93).
- Male sex stayed associated with PPCs across six regression models and after propensity matching (adjusted OR 2.34, 95% CI 1.31-4.17), with no effect modification by ventilation duration, surgeon experience, or procedure type.
- Single-center retrospective cohort of 408 adults undergoing elective cardiovascular surgery (2022–2023), comparing a fixed postoperative dexmedetomidine infusion (n = 188) with no dexmedetomidine (n = 220).
- Exposure was a 24-hour infusion at 0.2 μg/kg/h versus no postoperative dexmedetomidine, with delirium assessed by CAM-ICU at 6 and 24 hours.
- Delirium was less frequent with dexmedetomidine at 6 hours (2.1% vs 7.0%, p = 0.032) and 24 hours (0.5% vs 3.6%, p = 0.042); adjusted OR at 6 hours was 0.25 (95% CI 0.07–0.88).
- Dexmedetomidine was also linked to shorter extubation time (6.85 ± 1.49 vs 9.47 ± 5.61 hours, p < 0.001) and similar adverse events and mortality, though the authors call for prospective confirmation.
- This is a review synthesizing evidence on helicopter retrieval of cardiovascular patients supported by VA-ECMO, with no sample size reported.
- It examines flight-specific stressors and technical circuit-stability innovations, using mitigation of category 2 severe complications as the benchmark of transport success.
- The abstract reports no quantitative effect sizes or CIs; it states that peri-transport mortality is negligible in specialized programs.
- The authors propose a standardized framework for transport safety and conclude that high-fidelity monitoring remains essential.
- This is a 2025 special review article in an annual series summarizing recent vascular anesthesia literature.
- It covers prophylactic versus rescue subarachnoid drains in endovascular aortic repair, and perioperative blood pressure management in chronic hypertension.
- It also addresses preoperative risk stratification and ischemic heart disease evaluation, plus new guidelines for descending thoracic and thoracoabdominal aortic pathologies.
- Systematic review and meta-analysis of 20 studies including 19,918 patients undergoing lung resection surgery.
- Evaluated goal-directed fluid therapy as a preventive strategy and linked acute kidney injury to postoperative outcomes.
- Pooled AKI incidence was 5.31% (95% CI, 3.61%-6.70%); AKI was tied to longer stay (MD 0.92 days; 95% CI, 0.52-1.30) and short-term mortality (RR 5.60; 95% CI, 1.66-18.83).
- Goal-directed fluid therapy did not significantly reduce AKI risk (RR 0.64; 95% CI, 0.32-1.27), and the authors call AKI a prognostic indicator warranting early risk stratification.
AI summary not available. Read the source abstract on PubMed.
- Single-center retrospective cohort of adults who developed AKI requiring CRRT after cardiac surgery, 2013–2022, excluding CKD stage 4–5 and maintenance dialysis.
- Cox regression identified factors associated with in-hospital mortality, and ROC curves compared SOFA, APACHE II, and EuroSCORE II; no study intervention was given.
- In-hospital mortality was 50.5%; each 1-point SOFA increase carried HR 1.46 (95% CI, 1.36-1.56), and SOFA's AUC of 0.93 exceeded APACHE II (0.72) and EuroSCORE II (0.61).
- IABP use (HR 2.11) and mechanical ventilation over 96 hours (HR 3.06) were also independent predictors, and the authors suggest SOFA could support early risk stratification.